{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:26:32Z","timestamp":1783776392582,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006396","name":"Qazvin University of Medical Sciences","doi-asserted-by":"publisher","award":["28\/20\/15215"],"award-info":[{"award-number":["28\/20\/15215"]}],"id":[{"id":"10.13039\/501100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.diagmicrobio.2024.116668","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T22:51:26Z","timestamp":1734735086000},"page":"116668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative efficacy of HPV 16\/18 DNA and E6\/E7 mRNA testing in detecting high-grade cervical lesions (CIN2+) in women with cervical biopsies"],"prefix":"10.1016","volume":"111","author":[{"given":"Sepideh","family":"Benvari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Aslanimehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Samiee-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghi","family":"Naserpour-Farivar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116668_bib0001","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"The Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116668_bib0002","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2021.01.020","article-title":"High-risk HPV-positive and-negative high-grade cervical dysplasia: aanalysis of 5-year outcomes","volume":"161","author":"Bogani","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"13","key":"10.1016\/j.diagmicrobio.2024.116668_bib0003","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/1471-0528.16857","article-title":"Effect of the COVID-19 pandemic on oncology screenings: it is time to change course","volume":"128","author":"Scioscia","year":"2021","journal-title":"Bjog"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116668_bib0004","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s10147-023-02340-y","article-title":"Papillomaviruses and cancer: ccommonalities and differences in HPV carcinogenesis at different sites of the body","volume":"28","author":"Egawa","year":"2023","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116668_bib0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.34172\/bi.2020.30","article-title":"Classification and identification of human papillomavirus based on its prevalence and development of cervical lesion among Iranian women","volume":"10","author":"Moeinzadeh","year":"2020","journal-title":"BioImpacts: BI"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116668_bib0006","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.4424","article-title":"Are 20 human papillomavirus types causing cervical cancer?","volume":"234","author":"Arbyn","year":"2014","journal-title":"J Pathol"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116668_bib0007","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/infdis\/jiaa587","article-title":"How many Human papillomavirus types do we need to screen for?","volume":"223","author":"Sundstr\u00f6m","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116668_bib0008","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2147\/TCRM.S81825","article-title":"Recurrent respiratory papillomatosis: current and future perspectives","author":"Carifi","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.diagmicrobio.2024.116668_bib0009","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human papillomavirus molecular biology and disease association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.diagmicrobio.2024.116668_bib0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virusres.2016.12.017","article-title":"The low-risk papillomaviruses","volume":"231","author":"Egawa","year":"2017","journal-title":"Virus Res"},{"issue":"1\u20132","key":"10.1016\/j.diagmicrobio.2024.116668_bib0011","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.virol.2013.04.023","article-title":"Cross-roads in the classification of papillomaviruses","volume":"445","author":"de Villiers","year":"2013","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2024.116668_bib0012","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41416-020-0790-1","article-title":"Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening","volume":"122","author":"Hashim","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.diagmicrobio.2024.116668_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13027-020-00291-x","article-title":"Risk of cervical lesions in high-risk HPV positive women with normal cytology: a retrospective single-center study in China","volume":"15","author":"Wang","year":"2020","journal-title":"Infect Agent Cancer"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116668_bib0014","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3390\/cancers12061528","article-title":"Prevalence and type distribution of high-risk Human papillomavirus (HPV) in breast cancer: a Qatar based study","volume":"12","author":"Sher","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116668_bib0015","doi-asserted-by":"crossref","first-page":"001","DOI":"10.17352\/acp.000011","article-title":"Evaluation of different guidelines for cervical cancer screening and management of abnormal cervical cytology","volume":"5","author":"Ismail","year":"2020","journal-title":"Ann Cytol Pathol"},{"key":"10.1016\/j.diagmicrobio.2024.116668_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2023.122339","article-title":"H-CNN combined with tissue raman spectroscopy for cervical cancer detection","volume":"291","author":"Kang","year":"2023","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116668_bib0017","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/jog.14168","article-title":"Screening and management of preinvasive lesions of the cervix: ggood clinical practice recommendations from the Federation of Obstetrics and Gynaecologic Societies of India (FOGSI)","volume":"46","author":"Bhatla","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116668_bib0018","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1043659619846247","article-title":"Barriers to cervical cancer screening and treatment in the Dominican Republic: perspectives of focus group participants in the Santo Domingo area","volume":"31","author":"Liebermann","year":"2020","journal-title":"J Transcult Nurs"},{"key":"10.1016\/j.diagmicrobio.2024.116668_bib0019","doi-asserted-by":"crossref","first-page":"e8152","DOI":"10.7717\/peerj.8152","article-title":"Evaluation of human-papillomavirus screening for cervical cancer in China's rural population","volume":"7","author":"Li","year":"2019","journal-title":"PeerJ"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2024.116668_bib0020","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.bjc.6601691","article-title":"Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones","volume":"90","author":"Kraus","year":"2004","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116668_bib0021","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12905-023-02538-2","article-title":"Detection of cervical high-grade squamous intraepithelial lesions and assessing diagnostic performance of colposcopy among women with oncogenic HPV","volume":"23","author":"Li","year":"2023","journal-title":"BMC Womens Health"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116668_bib0022","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4103\/apjon.apjon_15_18","article-title":"A study on cervical cancer screening using pap smear test and clinical correlation","volume":"5","author":"Sachan","year":"2018","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116668_bib0023","first-page":"780","article-title":"New tests for cervical cancer screening","volume":"64","author":"Nuovo","year":"2001","journal-title":"Am Fam Physic"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116668_bib0024","first-page":"1734","article-title":"Assessment of cervical cancer molecular-based screening tools; HPV-DNA detection versus E6\/E7 mRNA testing; first re-port of a prospective cohort study among Iranian women","volume":"49","author":"Mousavi","year":"2020","journal-title":"Iran J Public Health"},{"key":"10.1016\/j.diagmicrobio.2024.116668_bib0025","first-page":"2020","article-title":"Perspectives in HPV secondary screening and personalized therapy basing on our understanding of HPV-related carcinogenesis pathways","author":"Celewicz","year":"2020","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.diagmicrobio.2024.116668_bib0026","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.2147\/OTT.S264312","article-title":"Cervical cancer: eemerging immune landscape and treatment","volume":"13","author":"Guo","year":"2020","journal-title":"Onco Target Ther"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116668_bib0027","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/jmp4020008","article-title":"Performance of a 7-type HPV mRNA test in triage of HPV DNA primary screen positive women compared to liquid-based cytology","volume":"4","author":"S\u00f8rbye","year":"2023","journal-title":"J Mol Patho"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116668_bib0028","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/cancers12030646","article-title":"The interplay between antiviral signalling and carcinogenesis in Human papillomavirus infections","volume":"12","author":"Ferreira","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116668_bib0029","first-page":"3316","article-title":"Comprehensive gene and pathway analysis of cervical cancer progression","volume":"19","author":"Yi","year":"2020","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116668_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13027-020-0278-x","article-title":"HPV E6\/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review","volume":"15","author":"Derbie","year":"2020","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.diagmicrobio.2024.116668_bib0031","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijid.2018.09.014","article-title":"Diagnostic performance of the E6\/E7 mRNA-based optimygene HR-HPV RT-qDx assay for cervical cancer screening","volume":"78","author":"Wang","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116668_bib0032","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/diagnostics13050917","article-title":"E6\/E7 mRNA expression of the most prevalent high-risk HPV genotypes in cervical samples from Serbian Women","volume":"13","author":"Nikolic","year":"2023","journal-title":"Diagnostics"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116668_bib0033","doi-asserted-by":"crossref","first-page":"e12724","DOI":"10.1371\/journal.pone.0012724","article-title":"Triage of women with minor cervical lesions: data suggesting a \u201ctest and treat\u201d approach for HPV E6\/E7 mRNA testing","volume":"5","author":"S\u00f8rbye","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116668_bib0034","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ijc.31633","article-title":"Eight-type human papillomavirus E6\/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women","volume":"144","author":"Rezhake","year":"2019","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2024.116668_bib0035","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1128\/JCM.01733-08","article-title":"RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus","volume":"47","author":"Cattani","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116668_bib0036","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/03630242.2020.1822490","article-title":"Distribution of the most common types of HPV in Iranian women with and without cervical cancer","volume":"61","author":"Farahmand","year":"2021","journal-title":"Women Health"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116668_bib0037","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1002\/jmv.26928","article-title":"A meta-analysis of human papillomavirus prevalence and types among Iranian women with normal cervical cytology, premalignant lesions, and cervical cancer","volume":"93","author":"Salavatiha","year":"2021","journal-title":"J of Med Virol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116668_bib0038","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2478\/prilozi-2019-0003","article-title":"Comparison between HPV DNA testing and HPV E6\/E7 MRNA testing in women with squamous cell abnormalities of the uterine cervix","volume":"40","author":"Dabeski","year":"2019","journal-title":"pril"},{"key":"10.1016\/j.diagmicrobio.2024.116668_bib0039","article-title":"The potential benefits of HPV E6\/E7 mRNA test in cervical cancer screening in China","volume":"10","author":"Zhang","year":"2020","journal-title":"Fron Oncol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116668_bib0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3906\/sag-1508-155","article-title":"HPV types and E6\/E7 mRNA expression in cervical samples from Turkish women with abnormal cytology in Ankara, Turkey","volume":"47","author":"T\u00fcney","year":"2017","journal-title":"Turk J Med Sci"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116668_bib0041","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/JCM.44.4.1310-1317.2006","article-title":"Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas","volume":"44","author":"Kraus","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116668_bib0042","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1631\/jzus.B1600288","article-title":"Human papillomavirus (HPV) E6\/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women","volume":"18","author":"Y-l","year":"2017","journal-title":"J Zhejiang Univ Sci B"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116668_bib0043","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1158\/1078-0432.CCR-06-2881","article-title":"A cross-sectional study of a prototype carcinogenic human papillomavirus E6\/E7 messenger RNA assay for detection of cervical precancer and cancer","volume":"13","author":"Castle","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116668_bib0044","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0036-1580713","article-title":"High risk HPV E6\/E7 oncoprotein expression in women with high grade squamous intraepithelial lesion","volume":"38","author":"Valen\u00e7a","year":"2016","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116668_bib0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12985-018-0957-z","article-title":"HPV genotype determination and E6\/E7 mRNA detection for management of HPV positive women","volume":"15","author":"Bruno","year":"2018","journal-title":"Virol J"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116668_bib0046","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jmv.20153","article-title":"Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction","volume":"74","author":"Sotlar","year":"2004","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116668_bib0047","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4238\/gmr.15017916","article-title":"Expression of human papillomavirus E6 and E7 oncoprotein mRNA in women with low-grade squamous intraepithelial lesions or less","volume":"15","author":"Casagrande","year":"2016","journal-title":"Genet Mol Res"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116668_bib0048","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/cyt.12835","article-title":"The early detection of cervical cancer. The current and changing landscape of cervical disease detection","volume":"31","author":"Shiraz","year":"2020","journal-title":"Cytopathology"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116668_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-019-1251-4","article-title":"Prognostic and diagnostic validity of p16\/ki-67, HPV E6\/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study","volume":"16","author":"Ren","year":"2019","journal-title":"Virol J"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116668_bib0050","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jnci\/djaa105","article-title":"p16\/ki67 and E6\/E7 mRNA accuracy and prognostic value in triaging HPV DNA-positive women","volume":"113","author":"Giorgi Rossi","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2024.116668_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15123106","article-title":"Risk of intraepithelial neoplasia grade 3 or worse (CIN3+) among women examined by a 5-type HPV mRNA test during 2003 and 2004, followed through 2015","volume":"15","author":"Rad","year":"2023","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2024.116668_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275858","article-title":"Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+ in young women with normal cervical cytology","volume":"17","author":"Al-Shibli","year":"2022","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116668_bib0053","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011981","article-title":"Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study","volume":"6","author":"S\u00f8rbye","year":"2016","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116668_bib0054","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/ijc.31819","article-title":"HPV-mRNA and HPV-DNA detection in samples taken up to seven years before severe dysplasia of cervix uteri","volume":"144","author":"Forslund","year":"2019","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116668_bib0055","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/cncr.10439","article-title":"Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis","volume":"94","author":"Wang-Johanning","year":"2002","journal-title":"Cancer"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324004929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324004929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T09:05:54Z","timestamp":1740560754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889324004929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0732889324004929"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116668","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy of HPV 16\/18 DNA and E6\/E7 mRNA testing in detecting high-grade cervical lesions (CIN2+) in women with cervical biopsies","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116668"}}